Position in JNJ
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$712,893
+$26,750 QoQ
Shares Held
2,807
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#3,347
of 4,676 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ruggaard & Associates LLC holds $2,434,853 across 3 Drug Manufacturers - General names. JNJ ranks #2 (29.3% of the industry book) .
All Filings in JNJ
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $712,893 | 2,807 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $686,143 | 2,807 | Shares | Sole | 2026-05-26 | |
| 2025-12-31 | $580,908 | 2,807 | Shares | Sole | 2026-02-20 | |
| 2025-09-30 | $520,473 | 2,807 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $428,922 | 2,808 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $659,711 | 3,978 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $593,375 | 4,103 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $665,418 | 4,106 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $607,440 | 4,156 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $658,861 | 4,165 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $661,442 | 4,220 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $686,546 | 4,408 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $744,508 | 4,498 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $707,420 | 4,564 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||